Metronidazole-13C2,15N2

• UNSPSC Description:

  Metronidazole-13C2,15N2 is the 13C-labeled and 15N-labeled Metronidazole. Metronidazole is a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa.

• Target Antigen:

  Antibiotic; Apoptosis; Bacterial; Isotope-Labeled Compounds; Parasite

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Anti-infection;Apoptosis;Others

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/metronidazole-13c2-15n2.html

• Purity:

  99.30

• Solubility:

  DMSO : 35 mg/mL (ultrasonic;warming)

• Smiles:

  OCC[15N]1C([N+]([O-])=O)=C[15N]=[13C]1[13CH3]

• Molecular Weight:

  175.13

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |[2]In Schaechter, M.; Engleberg, N. C.; DiRita, V. J. et al. Schaechter's Mechanisms of Microbial Disease. Hagerstown, MD: Lippincott Williams & Wilkins. p. 28.|[3]http://www.drugs.com/monograph/metronidazole.html|[4]Cohen, S.H., et al., Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol, 2010. 31(5): p. 431-55.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, sealed storage, away from moisture)

• Clinical Information:

  No Development Reported

• CAS Number:

  1173020-03-5